Invasive fungal diseases (IFD) are important causes of morbidity and mortality in children with hematological malignancies.Although Candida remains the most common fungal pathogen in oncology patients, the epidemiology has recently shifted toward non-albicans species.However, Aspergillus has also seen a recent rise.Early recognition and prompt antifungal treatment are key to the control of IFD.We provide clinicians with evidence-based recommendations on strategies for disease diagnosis and management in this review.
Key words:
Hematologic malignancies; Invasive fungal disease; Children